CVS Health Corporation (NYSE:CVS) posted an annual revenue of $292.11 billion for 2021, signaling an increase of 8.71% from 2020. In February, the firm announced the launch of six new innovative home health care products as an extension of the company's exclusive CVS Health product line. CVS Health Corporation (NYSE:CVS) stated in its fourth quarter earnings conference call that it was entering 2022 with a 'positive momentum', and sees a clear pathway to low double digit EPS growth.